Oroxylin A inhibits matrix metalloproteinase-2/9 expression and activation by up-regulating tissue inhibitor of metalloproteinase-2 and suppressing the ERK1/2 signaling pathway

Zhijian Lu(China Pharmaceutical University), Qinglong Guo(Nanjing Tech University), Biqi Lin(China Pharmaceutical University), Na Lu(Shandong Maternal and Child Health Hospital), Chenglin Li(State Key Laboratory of Natural Medicine), Kai Zhao(Qingdao University), Fanni Li(First Affiliated Hospital of Xi'an Jiaotong University)
Toxicology Letters
January 11, 2012
10.1016/j.toxlet.2011.12.022
Cited by 62

Related Papers

Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma
|Journal of Experimental & Clinical Cancer Research|2019|150
ACPAs promote IL-1β production in rheumatoid arthritis by activating the NLRP3 inflammasome
|Cellular and Molecular Immunology|2019|115
Artemisinin derivatives inactivate cancer-associated fibroblasts through suppressing TGF-β signaling in breast cancer
|Journal of Experimental & Clinical Cancer Research|2018|93
Overview of AKR1C3: Inhibitor Achievements and Disease Insights
|Journal of Medicinal Chemistry|2020|92
Oroxylin A inhibits glycolysis-dependent proliferation of human breast cancer via promoting SIRT3-mediated SOD2 transcription and HIF1α destabilization
|Cell Death and Disease|2015|87